Free Trial

BioNexus Gene Lab Q1 2024 Earnings Report

$0.23 -0.03 (-12.80%)
(As of 12/20/2024 05:31 PM ET)

BioNexus Gene Lab EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioNexus Gene Lab Revenue Results

Actual Revenue
$2.38 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioNexus Gene Lab Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

BioNexus Gene Lab Earnings Headlines

BioNexus Gene Lab Leads Our Top 3 US Penny Stocks
BioNexus Gene Lab Faces Delisting and Leadership Changes
I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
BioNexus partners with Vitarray for gene detection
European Central Bank cuts key interest rates as inflation falls
See More BioNexus Gene Lab Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioNexus Gene Lab? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNexus Gene Lab and other key companies, straight to your email.

About BioNexus Gene Lab

BioNexus Gene Lab (NASDAQ:BGLC), through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

View BioNexus Gene Lab Profile

More Earnings Resources from MarketBeat

Upcoming Earnings